SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000914121-22-003216
Filing Date
2022-04-26
Accepted
2022-04-25 21:54:21
Documents
1
Group Members
CHRISTOPHER COXCLIVE MEANWELLPOPULATION HEALTH EQUITY PARTNERS III GP, LLCPOPULATION HEALTH EQUITY PARTNERS VII GP, LLCPOPULATION HEALTH EQUITY PARTNERS VII, L.P.

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D (AMENDMENT NO. 1) ph20220425-sc13da.htm SC 13D/A 115418
  Complete submission text file 0000914121-22-003216.txt   117316
Mailing Address 1601 TRAPELO ROAD SUITE 178 WALTHAM MA 02451
Business Address 1601 TRAPELO ROAD SUITE 178 WALTHAM MA 02451 (781) 819-0080
Adagio Therapeutics, Inc. (Subject) CIK: 0001832038 (see all company filings)

IRS No.: 851403134 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-92804 | Film No.: 22851589
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O POPULATION HEALTH EQUITY PARTNERS LP 1200 MORRIS TURNPIKE, SUITE 3005 SHORT HILLS NJ 07078
Business Address C/O POPULATION HEALTH EQUITY PARTNERS LP 1200 MORRIS TURNPIKE, SUITE 3005 SHORT HILLS NJ 07078 (212)-993-3113
Population Health Equity Partners III, L.P. (Filed by) CIK: 0001921616 (see all company filings)

IRS No.: 853693519 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A